Determinants of Interindividual Variation in Exercise-Induced Cardiac Troponin I Levels

Magnus Bjørkavoll-Bergseth, Christine Bjørkvik Erevik, Øyunn Kleiven, Thijs M H Eijsvogels, Øyvind Skadberg, Vidar Frøysa, Tomasz Wiktorski, Bjørn Auestad, Thor Edvardsen, Kristin Moberg Aakre, Stein Ørn, Magnus Bjørkavoll-Bergseth, Christine Bjørkvik Erevik, Øyunn Kleiven, Thijs M H Eijsvogels, Øyvind Skadberg, Vidar Frøysa, Tomasz Wiktorski, Bjørn Auestad, Thor Edvardsen, Kristin Moberg Aakre, Stein Ørn

Abstract

Background Postexercise cardiac troponin levels show considerable interindividual variations. This study aimed to identify the major determinants of this postexercise variation in cardiac troponin I (cTnI) following 3 episodes of prolonged high-intensity endurance exercise. Methods and Results Study subjects were recruited among prior participants in a study of recreational cyclists completing a 91-km mountain bike race in either 2013 or 2014 (first race). In 2018, study participants completed a cardiopulmonary exercise test 2 to 3 weeks before renewed participation in the same race (second race). Blood was sampled before and at 3 and 24 hours following all exercises. Blood samples were analyzed using the same Abbot high-sensitivity cTnI STAT assay. Fifty-nine individuals (aged 50±9 years, 13 women) without cardiovascular disease were included. Troponin values were lowest before, highest at 3 hours, and declining at 24 hours. The largest cTnI difference was at 3 hours following exercise between the most (first race) (cTnI: 200 [87-300] ng/L) and the least strenuous exercise (cardiopulmonary exercise test) (cTnI: 12 [7-23] ng/L; P<0.001). The strongest correlation between troponin values at corresponding times was before exercise (r=0.92, P<0.0001). The strongest correlations at 3 hours were between the 2 races (r=0.72, P<0.001) and at 24 hours between the cardiopulmonary exercise test and the second race (r=0.83, P<0.001). Participants with the highest or lowest cTnI levels showed no differences in race performance or baseline echocardiographic parameters. Conclusions The variation in exercise-induced cTnI elevation is largely determined by a unique individual cTnI response that is dependent on the duration of high-intensity exercise and the timing of cTnI sampling. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT02166216.

Keywords: biomarkers; exercise physiology; troponin.

Conflict of interest statement

Ø.S. has received lecture fees from Abbott Diagnostics. The remaining authors have no disclosures to report.

Figures

Figure 1. Flowchart of the study.
Figure 1. Flowchart of the study.
CPX indicates cardiopulmonary exercise; T0, recruitment race; T1 cardiopulmonary exercise test 2018; and T2, 2018 race.
Figure 2. Cardiac troponin I (cTnI), at…
Figure 2. Cardiac troponin I (cTnI), at baseline, 3 h, and 24 h, after the cardiopulmonary exercise test in 2018 (T1), the North Sea Race in 2018 (T2), and the North Sea Race recruitment race in either 2013 or 2014 (T0).
Scale is log10‐transformed. Dotted lines indicate the 99th percentile of the high‐sensitivity cTnI assay (26 ng/L).
Figure 3. Consistency in ranking of cardiac…
Figure 3. Consistency in ranking of cardiac troponin I (cTnI) values following the recruitment race (the North Sea Race in either 2013 or 2014) and the 2018 North Sea Race.
Low responders are defined as individuals with a cTnI value within the first quartile (Q1) of the recruitment race (T0), whereas high responders are defined as individuals with a cTnI value within the highest quartile (Q4) of the recruitment race (T0). The graph displays the number of individuals in each of the 4 quartiles based on the cTnI values achieved in the 2018 race (T2). T0 indicates recruitment race; T1 cardiopulmonary exercise test 2018; and T2, 2018 race.
Figure 4. Scatterplot shows individual cardiac troponin…
Figure 4. Scatterplot shows individual cardiac troponin I (cTnI) response at baseline, 3 h, and 24 h after the cardiopulmonary exercise (CPX) test in 2018 (T1), the 2018 race (T2), and the recruitment race in either 2013 or 2014 (T0).
Spearman bivariate correlations were used to assess the correlations between time points. Dotted lines indicate the 99th percentile of the high‐sensitivity cTnI assay (26 ng/L).

References

    1. Sigurdardottir FD, Lyngbakken MN, Holmen OL, Dalen H, Hveem K, Rosjo H, Omland T. Relative prognostic value of cardiac troponin i and c‐reactive protein in the general population (from the Nord‐Trondelag Health [HUNT] Study). Am J Cardiol. 2018;121:949–955. doi: 10.1016/j.amjcard.2018.01.004
    1. Thorsteinsdottir I, Aspelund T, Gudmundsson E, Eiriksdottir G, Harris TB, Launer LJ, Gudnason V, Venge P. High‐sensitivity cardiac troponin i is a strong predictor of cardiovascular events and mortality in the AGES‐Reykjavik community‐based cohort of older individuals. Clin Chem. 2016;62:623–630. doi: 10.1373/clinchem.2015.250811
    1. Stavroulakis GA, George KP. Exercise‐induced release of troponin. Clin Cardiol. 2020;43:872–881. DOI: 10.1002/clc.23337.
    1. Aengevaeren VL, Hopman MTE, Thompson PD, Bakker EA, George KP, Thijssen DHJ, Eijsvogels TMH. Exercise‐induced cardiac troponin I increase and incident mortality and cardiovascular events. Circulation. 2019;140:804–814. doi: 10.1161/CIRCULATIONAHA.119.041627
    1. Kleiven O, Omland T, Skadberg O, Melberg TH, Bjorkavoll‐Bergseth MF, Auestad B, Bergseth R, Greve OJ, Aakre KM, Orn S. Occult obstructive coronary artery disease is associated with prolonged cardiac troponin elevation following strenuous exercise. Eur J Prev Cardiol. 2020;27:1212–1221. doi: 10.1177/2047487319852808
    1. Donaldson JA, Wiles JD, Coleman DA, Papadakis M, Sharma R, O'Driscoll JM. Left ventricular function and cardiac biomarker release‐the influence of exercise intensity, duration and mode: a systematic review and meta‐analysis. Sports Med. 2019;49:1275–1289. doi: 10.1007/s40279-019-01142-5
    1. Eijsvogels TM, Hoogerwerf MD, Oudegeest‐Sander MH, Hopman MT, Thijssen DH. The impact of exercise intensity on cardiac troponin I release. Int J Cardiol. 2014;171:e3–e4. doi: 10.1016/j.ijcard.2013.11.050
    1. Martinez‐Navarro I, Sanchez‐Gomez J, Sanmiguel D, Collado E, Hernando B, Panizo N, Hernando C. Immediate and 24‐h post‐marathon cardiac troponin T is associated with relative exercise intensity. Eur J Appl Physiol. 2020;120:1723–1731. doi: 10.1007/s00421-020-04403-8
    1. Kleiven O, Omland T, Skadberg O, Melberg TH, Bjorkavoll‐Bergseth MF, Auestad B, Bergseth R, Greve OJ, Aakre KM, Orn S. Race duration and blood pressure are major predictors of exercise‐induced cardiac troponin elevation. Int J Cardiol. 2019;283:1–8. doi: 10.1016/j.ijcard.2019.02.044
    1. Bjørkavoll‐Bergseth M, Kleiven Ø, Auestad B, Eftestøl T, Oskal K, Nygård M, Skadberg Ø, Aakre KM, Melberg T, Gjesdal K, et al. Duration of elevated heart rate is an important predictor of exercise‐induced troponin elevation. J Am Heart Assoc. 2020;9:e014408. doi: 10.1161/JAHA.119.014408
    1. Skadberg O, Kleiven O, Orn S, Bjorkavoll‐Bergseth MF, Melberg TH, Omland T, Aakre KM. The cardiac troponin response following physical exercise in relation to biomarker criteria for acute myocardial infarction; the North Sea Race Endurance Exercise Study (NEEDED) 2013. Clin Chim Acta. 2018;479:155–159. doi: 10.1016/j.cca.2018.01.033
    1. Kleiven Ø, Bjørkavoll‐Bergseth MF, Omland T, Aakre KM, Frøysa V, Erevik CB, Greve OJ, Melberg TH, Auestad B, Skadberg Ø, et al. Endurance exercise training volume is not associated with progression of coronary artery calcification. Scand J Med Sci Sports. 2020;30:1024–1032. doi: 10.1111/sms.13643
    1. Kurtze N, Rangul V, Hustvedt BE. Reliability and validity of the international physical activity questionnaire in the Nord‐Trondelag health study (HUNT) population of men. BMC Med Res Methodol. 2008;8:63. doi: 10.1186/1471-2288-8-63
    1. Reiser M, Meyer T, Kindermann W, Daugs R. Transferability of workload measurements between three different types of ergometer. Eur J Appl Physiol. 2000;82:245–249. doi: 10.1007/s004210050678
    1. Granier C, Hausswirth C, Dorel S, Le Meur Y. Validity and reliability of the stages cycling power meter. J Strength Cond Res. 2020;34:3554–3559. doi: 10.1519/JSC.0000000000002189
    1. Gobel FL, Norstrom LA, Nelson RR, Jorgensen CR, Wang Y. The rate‐pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. Circulation. 1978;57:549–556. doi: 10.1161/01.CIR.57.3.549
    1. Ifcc C. High‐Sensitivity* Cardiac Troponin I and T Assay Analytical Characteristics Designated by Manufacturer . IFCC Committee on Clinical Applications of Cardiac Bio‐Markers (C‐CB). Milan, Italy; 2018.
    1. Lang RM, Badano LP, Mor‐Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:e14. doi: 10.1016/j.echo.2014.10.003
    1. Gresslien T, Agewall S. Troponin and exercise. Int J Cardiol. 2016;221:609–621. doi: 10.1016/j.ijcard.2016.06.243
    1. Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem. 2012;58:1574–1581. doi: 10.1373/clinchem.2012.192716
    1. Stewart GM, Yamada A, Haseler LJ, Kavanagh JJ, Chan J, Koerbin G, Wood C, Sabapathy S. Influence of exercise intensity and duration on functional and biochemical perturbations in the human heart. J Physiol. 2016;594:3031–3044. doi: 10.1113/JP271889
    1. Richardson AJ, Leckie T, Watkins ER, Fitzpatrick D, Galloway R, Grimaldi R, Baker P. Post marathon cardiac troponin T is associated with relative exercise intensity. Journal of science and medicine in sport. 2018;21:880–884. doi: 10.1016/j.jsams.2018.02.005
    1. Eijsvogels TM, Hoogerwerf MD, Maessen MF, Seeger JP, George KP, Hopman MT, Thijssen DH. Predictors of cardiac troponin release after a marathon. Journal of science and medicine in sport. 2015;18:88–92. doi: 10.1016/j.jsams.2013.12.002
    1. Mingels A, Jacobs L, Michielsen E, Swaanenburg J, Wodzig W, van Dieijen‐Visser M. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem. 2009;55:101–108. doi: 10.1373/clinchem.2008.106427
    1. Scherr J, Braun S, Schuster T, Hartmann C, Moehlenkamp S, Wolfarth B, Pressler A, Halle M. 72‐h kinetics of high‐sensitive troponin T and inflammatory markers after marathon. Med Sci Sports Exerc. 2011;43:1819–1827. doi: 10.1249/MSS.0b013e31821b12eb
    1. Sahlen A, Gustafsson TP, Svensson JE, Marklund T, Winter R, Linde C, Braunschweig F. Predisposing factors and consequences of elevated biomarker levels in long‐distance runners aged ≥55 years. Am J Cardiol. 2009;104:1434–1440. doi: 10.1016/j.amjcard.2009.06.067
    1. Mehta R, Gaze D, Mohan S, Williams KL, Sprung V, George K, Jeffries R, Hudson Z, Perry M, Shave R. Post‐exercise cardiac troponin release is related to exercise training history. Int J Sports Med. 2012;33:333–337. doi: 10.1055/s-0031-1301322
    1. Hessel MH, Atsma DE, van der Valk EJ, Bax WH, Schalij MJ, van der Laarse A. Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation. Pflugers Arch. 2008;455:979–986. doi: 10.1007/s00424-007-0354-8
    1. Soetkamp D, Raedschelders K, Mastali M, Sobhani K, Bairey Merz CN, Van Eyk J. The continuing evolution of cardiac troponin I biomarker analysis: from protein to proteoform. Expert Rev Proteomics. 2017;14:973–986. doi: 10.1080/14789450.2017.1387054
    1. Vroemen WHM, Mezger STP, Masotti S, Clerico A, Bekers O, de Boer D, Mingels A. Cardiac troponin T: only small molecules in recreational runners after marathon completion. J Appl Lab Med. 2019;3:909–911. doi: 10.1373/jalm.2018.027144

Source: PubMed

3
Se inscrever